Exelixis (EX9) Stock Forecast & Price Target
3 Followers
EX9 Analyst Ratings
Hold
4Buy9Hold1Sell
Based on 14 analysts giving stock ratings to Exelixis in the past 3 months
EX9 Stock 12 Month Forecast
Average Price Target
CHF 48.24â–¼(-9.74% Downside)Based on 14 Wall Street analysts offering 12 month price targets for Exelixis in the last 3 months. The average price target is CHF 48.24 with a high forecast of CHF 63.51 and a low forecast of CHF 33.38. The average price target represents a -9.74% change from the last price of CHF 53.45.
Past 12 Months12 Month ForecastJan2026Oct2026
HighCHF 63.51
AverageCHF 48.24
LowCHF 33.38
Highest Price TargetHighestCHF 63.51Average Price TargetCHF 48.24Lowest Price TargetLowestCHF 33.38
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Andrew Berens | Leerink Partners | CHF 44.78→CHF 47.23 | hold | -11.65%Downside | Reiterated | 11/05/26 | ||
| Robert Burns | H.C. Wainwright | CHF 45.60→CHF 63.51 | buy | 18.82%Upside | Reiterated | 11/02/26 | ||
| Etzer Darout | Barclays | CHF 39.90→CHF 43.97 | hold | -17.74%Downside | Reiterated | 10/30/26 | ||
| David Lebowitz | BMO Capital | CHF 43.97→CHF 48.86 | hold | -8.60%Downside | Assigned | 10/30/26 | ||
| Sean Laaman | Morgan Stanley | CHF 43.16→CHF 48.86 | hold | -8.60%Downside | Assigned | 10/30/26 | ||
| Yaron Werber | TD Cowen | CHF 44.78→CHF 61.88 | buy | 15.77%Upside | Reiterated | 10/30/26 | ||
| Gregory Renza | Truist Financial | CHF 43.97→CHF 48.86 | hold | -8.60%Downside | Reiterated | 10/30/26 | ||
| Stephen Willey | Stifel Nicolaus | CHF 41.53 | hold | -22.31%Downside | Reiterated | 10/30/26 | ||
| Leonid Timashev | RBC Capital | CHF 41.53→CHF 47.23 | hold | -11.65%Downside | Assigned | 10/29/26 | ||
 Unknown AnalystNot Ranked | Guggenheim | ― | hold | ― | Reiterated | 10/29/26 | ||
| Silvan Tuerkcan | Citizens JMP | CHF 44.78→CHF 52.93 | buy | -0.98%Downside | Reiterated | 10/19/26 | ||
| Jason Gerberry | Bank of America Securities | CHF 33.38 | sell | -37.54%Downside | Reiterated | 10/09/26 | ||
| Andy Hsieh | William Blair | ― | buy | ― | Reiterated | 09/11/26 | ||
| Eva Fortea Verdejo | Wells Fargo | CHF 39.90→CHF 40.71 | hold | -23.83%Downside | Assigned | 08/06/26 | ||
| Paul Choi | Goldman Sachs | CHF 52.11 | buy | -2.51%Downside | Reiterated | 08/05/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Andrew BerensLeerink Partners | HoldReiteratedCHF 44.78→CHF 47.23 | 11/05/26 | -11.65%Downside | ||
| Robert BurnsH.C. Wainwright | BuyReiteratedCHF 45.60→CHF 63.51 | 11/02/26 | 18.82%Upside | ||
| Etzer DaroutBarclays | HoldReiteratedCHF 39.90→CHF 43.97 | 10/30/26 | -17.74%Downside | ||
| David LebowitzBMO Capital | HoldAssignedCHF 43.97→CHF 48.86 | 10/30/26 | -8.60%Downside | ||
| Sean LaamanMorgan Stanley | HoldAssignedCHF 43.16→CHF 48.86 | 10/30/26 | -8.60%Downside | ||
| Yaron WerberTD Cowen | BuyReiteratedCHF 44.78→CHF 61.88 | 10/30/26 | 15.77%Upside | ||
| Gregory RenzaTruist Financial | HoldReiteratedCHF 43.97→CHF 48.86 | 10/30/26 | -8.60%Downside | ||
| Stephen WilleyStifel Nicolaus | HoldReiteratedCHF 41.53 | 10/30/26 | -22.31%Downside | ||
| Leonid TimashevRBC Capital | HoldAssignedCHF 41.53→CHF 47.23 | 10/29/26 | -11.65%Downside | ||
| Unknown AnalystGuggenheimNot Ranked | HoldReiterated | 10/29/26 | ― | ||
| Silvan TuerkcanCitizens JMP | BuyReiteratedCHF 44.78→CHF 52.93 | 10/19/26 | -0.98%Downside | ||
| Jason GerberryBank of America Securities | SellReiteratedCHF 33.38 | 10/09/26 | -37.54%Downside | ||
| Andy HsiehWilliam Blair | BuyReiterated | 09/11/26 | ― | ||
| Eva Fortea VerdejoWells Fargo | HoldAssignedCHF 39.90→CHF 40.71 | 08/06/26 | -23.83%Downside | ||
| Paul ChoiGoldman Sachs | BuyReiteratedCHF 52.11 | 08/05/26 | -2.51%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Exelixis
3 Months
Success Rate19/25 ratings generated profit
76%
Average Return
+9.58%
Copying Yaron Werber's trades and holding each position for 3 Months would result in 76.00% of your transactions generating a profit, with an average return of +9.58% per trade.
1 Year
Success Rate23/25 ratings generated profit
92%
Average Return
+34.36%
Copying Yaron Werber's trades and holding each position for 1 Year would result in 92.00% of your transactions generating a profit, with an average return of +34.36% per trade.
2 Years
Success Rate32/39 ratings generated profit
82%
Average Return
+69.97%
Copying Silvan Tuerkcan's trades and holding each position for 2 Years would result in 82.05% of your transactions generating a profit, with an average return of +69.97% per trade.
EX9 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 6 | 6 | 6 | 4 |
| Hold | 15 | 19 | 22 | 24 | 15 |
| Sell | 1 | 2 | 2 | 3 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 23 | 27 | 30 | 33 | 21 |
In the current month, EX9 has received 4 Buy Ratings, 15 Hold Ratings, and 2 Sell Ratings. EX9 average Analyst price target in the past 3 months is 48.24.
EX9 Financial Forecast
HighCHF 1.01
ConsensusCHF 0.79
LowCHF 0.45
EX9 Earnings Forecast
Next quarter’s earnings estimate for EX9 is CHF 0.79 with a range of CHF 0.45 to CHF 1.01. The previous quarter’s EPS was CHF 0.78. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF 567M
ConsensusCHF 543M
LowCHF 526M
EX9 Sales Forecast
Next quarter’s sales forecast for EX9 is CHF 543.08M with a range of CHF 526.47M to CHF 566.64M. The previous quarter’s sales results were CHF 543.30M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
EX9 Stock Forecast FAQ
What is CH:EX9’s average 12-month price target, according to analysts?
Based on analyst ratings, Exelixis’s 12-month average price target is CHF48.24.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Exelixis a Buy, Sell or Hold?
Exelixis has a consensus rating of Hold, which is based on 4 buy ratings, 9 hold ratings and 1 sell ratings.
What is Exelixis’s share price target?
The average share price target for Exelixis is CHF48.24. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF63.51, and the lowest forecast is CHF33.38. The average share price target represents a 9.74% decrease from the current price of CHF53.452.
What do analysts say about Exelixis?
Exelixis’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of Exelixis?
To buy shares of CH:EX9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
